This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

Prices will rise in...

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
12 - 14 Nov 2024
Hamburg Congress CenterHamburg, Germany

Marcus Reay
Business Development Manager at DelSiTech Ltd.
Speaker

Profile

Marcus Reay, MSc, is a silica drug delivery specialist across parenteral and topical ocular applications. Mr Reay is currently in a business development role at DelSiTech; however he is a biochemist by training, specializing in medical biotechnology with a focus on advancing long-acting controlled release drug delivery technology. Mr. Reay has previously spoken on controlled release mRNA formulations at the AsiaTIDES event in 2023 in Kyoto.

Agenda Sessions

  • Long-Acting Controlled Release of Antisense Oligonucleotides with Biodegradable Silica Composites

    17:00